HAEMONETICS CORP Common Stock Shares Outstanding

Quick Answer

HAEMONETICS CORP reported Common Stock Shares Outstanding of 48.22 million shares for the year ending 2025.

  • HAEMONETICS CORP showed a decrease of -5.1% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2010: 24.67 million shares | Q3 2010: 24.75 million shares | Q4 2010: 25.42 million shares | Q1 2011: 25.30 million shares | Q2 2011: 25.77 million shares | Q3 2011: 24.98 million shares | Q4 2011: 25.64 million shares | Q3 2012: 25.79 million shares | Q4 2012: 51.64 million shares | Q2 2013: 51.40 million shares | Q3 2013: 51.53 million shares | Q4 2013: 51.53 million shares | Q2 2014: 51.43 million shares | Q3 2014: 51.34 million shares | Q4 2014: 51.49 million shares | Q2 2015: 50.89 million shares | Q3 2015: 50.62 million shares | Q4 2015: 50.80 million shares | Q2 2016: 51.06 million shares | Q3 2016: 51.54 million shares | Q4 2016: 51.83 million shares | Q2 2017: 52.52 million shares | Q3 2017: 52.69 million shares | Q4 2017: 53.39 million shares | Q2 2018: 51.64 million shares | Q3 2018: 51.62 million shares | Q4 2018: 50.99 million shares | Q2 2019: 50.77 million shares | Q3 2019: 50.61 million shares | Q4 2019: 50.61 million shares | Q2 2020: 50.61 million shares | Q3 2020: 50.70 million shares | Q4 2020: 50.82 million shares | Q2 2021: 51.01 million shares | Q3 2021: 51.06 million shares | Q4 2021: 51.11 million shares | Q2 2022: 51.32 million shares | Q3 2022: 50.61 million shares | Q4 2022: 50.44 million shares | Q2 2023: 50.71 million shares | Q3 2023: 50.74 million shares | Q4 2023: 50.79 million shares | Q2 2024: 51.15 million shares | Q3 2024: 50.38 million shares | Q4 2024: 50.24 million shares | Q1 2025: 48.22 million shares | Q2 2025: 48.16 million shares | Q3 2025: 46.75 million shares | Q4 2025: 46.83 million shares.
  • Over the full 16 years of available data (2010 to 2025), HAEMONETICS CORP's Common Stock Shares Outstanding has grown by 89.5%.
  • Historical annual values: Fiscal year 2025: 48.22 million shares | Fiscal year 2024: 50.79 million shares | Fiscal year 2023: 50.45 million shares | Fiscal year 2022: 51.12 million shares | Fiscal year 2021: 50.87 million shares | Fiscal year 2020: 50.32 million shares | Fiscal year 2019: 51.02 million shares | Fiscal year 2018: 52.34 million shares | Fiscal year 2017: 52.26 million shares | Fiscal year 2016: 50.93 million shares | Fiscal year 2015: 51.67 million shares | Fiscal year 2014: 52.04 million shares | Fiscal year 2013: 51.03 million shares | Fiscal year 2012: 50.60 million shares | Fiscal year 2011: 25.66 million shares | Fiscal year 2010: 25.44 million shares.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: